The following articles (labelled with PubMed ID or TBD) are for your review
PMID | Data | Article Title | Organization |
27089209 |
50 |
Discovery and analgesic evaluation of 8-chloro-1,4-dihydropyrido[2,3-b]pyrazine-2,3-dione as a novel potent d-amino acid oxidase inhibitor. |
Shanghai Jiao Tong University |
26965861 |
15 |
D-Amino acid oxidase inhibitors based on the 5-hydroxy-1,2,4-triazin-6(1H)-one scaffold. |
Johns Hopkins University |
26322531 |
73 |
Identification of Novel D-Aspartate Oxidase Inhibitors by in Silico Screening and Their Functional and Structural Characterization in Vitro. |
Kitasato University |
26309148 |
43 |
6-Hydroxy-1,2,4-triazine-3,5(2H,4H)-dione Derivatives as Novel D-Amino Acid Oxidase Inhibitors. |
Johns Hopkins University |
25408840 |
2 |
Structure-Metabolism Relationships in the Glucuronidation of d-Amino Acid Oxidase Inhibitors. |
Johns Hopkins University |
23683589 |
21 |
Synthesis of kojic acid derivatives as secondary binding site probes of D-amino acid oxidase. |
Johns Hopkins University |
23631755 |
37 |
Structural, kinetic, and pharmacodynamic mechanisms of D-amino acid oxidase inhibition by small molecules. |
Sunovion Pharmaceuticals |
23540955 |
24 |
Synthesis and SAR study of new thiazole derivatives as vascular adhesion protein-1 (VAP-1) inhibitors for the treatment of diabetic macular edema: part 2. |
Astellas Pharma |
23566269 |
90 |
4-Hydroxypyridazin-3(2H)-one derivatives as novel D-amino acid oxidase inhibitors. |
Astellas Pharma |
23391306 |
75 |
Identification of novel D-amino acid oxidase inhibitors by in silico screening and their functional characterization in vitro. |
Kitasato University |
23337801 |
24 |
Synthesis and SAR study of new thiazole derivatives as vascular adhesion protein-1 (VAP-1) inhibitors for the treatment of diabetic macular edema. |
Astellas Pharma |
23243487 |
65 |
Synthesis and SAR of 1-hydroxy-1H-benzo[d]imidazol-2(3H)-ones as Inhibitors of D-Amino Acid Oxidase. |
TBA |
22595173 |
68 |
The discovery and development of selective 3-fluoro-4-aryloxyallylamine inhibitors of the amine oxidase activity of semicarbazide-sensitive amine oxidase/vascular adhesion protein-1 (SSAO/VAP-1). |
Pharmaxis |
21880399 |
35 |
Biophysical and physicochemical methods differentiate highly ligand-efficient human D-amino acid oxidase inhibitors. |
Abbott Healthcare Products |
18455394 |
34 |
The discovery of fused pyrrole carboxylic acids as novel, potent D-amino acid oxidase (DAO) inhibitors. |
Merck Sharp & Dohme |
31580073 |
92 |
Identification and Optimization of Mechanism-Based Fluoroallylamine Inhibitors of Lysyl Oxidase-like 2/3. |
Pharmaxis |
30265959 |
29 |
Structural basis for potent inhibition of d-amino acid oxidase by thiophene carboxylic acids. |
Tokushima University |
29699925 |
5 |
Discovery of d-amino acid oxidase inhibitors based on virtual screening against the lid-open enzyme conformation. |
Hungarian Academy of Sciences |
29472125 |
20 |
Discovery of isatin and 1H-indazol-3-ol derivatives as d-amino acid oxidase (DAAO) inhibitors. |
Hungarian Academy of Sciences |
16530804 |
4 |
3-Amidoquinuclidine derivatives: synthesis of compounds and inhibition of butyrylcholinesterase. |
University of Zagreb |
2537663 |
10 |
1-(m-chlorophenyl)piperazine (mCPP) interactions with neurotransmitter receptors in the human brain. |
Stanford University |
20455574 |
9 |
Site-activated chelators targeting acetylcholinesterase and monoamine oxidase for Alzheimer's therapy. |
The Weizmann Institute of Science |
14613321 |
28 |
Requirements for specific binding of low affinity inhibitor fragments to the SH2 domain of (pp60)Src are identical to those for high affinity binding of full length inhibitors. |
Aventis Pharma |